Valuation: Becton, Dickinson and Company

Market Cap 45.83B 40.22B 37.46B 34.45B 64.58B 4,379B 65.69B 444B 174B 2,172B 172B 168B 7,503B P/E 2026 *
36.2x
P/E 2027 * 23.6x
Enterprise Value 62.03B 54.43B 50.69B 46.62B 87.4B 5,926B 88.9B 601B 235B 2,939B 233B 228B 10,154B EV / Sales 2026 *
3.23x
EV / Sales 2027 * 3.02x
Free-Float
74.04%
Yield 2026 *
2.36%
Yield 2027 * 2.39%
1 week+8.28%
Current month+10.08%
1 month+6.35%
3 months+14.52%
6 months+8.84%
Current year+10.88%
1 week 133.06
Extreme 133.06
147.9
1 month 130.7
Extreme 130.7
147.9
3 years 111.9
Extreme 111.90117625
208.3
5 years 111.9
Extreme 111.90117625
210.13
10 years 111.9
Extreme 111.90117625
210.13
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
+1.07%+3.19%+16.07%-28.01% 45.83B
+1.98%+8.52%-14.74%-1.97% 187B
+1.33%+7.08%-5.14%-0.09% 111B
+0.63%+6.60%+10.58%+71.44% 62.18B
+0.34%-6.62%+21.84%+49.32% 48.4B
-0.88%+8.16% - - 34.26B
+0.84%+5.80%-15.42%-39.33% 28.88B
-0.89%-7.32%+31.33%-9.74% 23.72B
+1.12%+10.71%+2.08%+3.36% 22.45B
+4.08%+6.34%-8.01%+5.00% 20.63B
Average +0.97%+1.47%+4.29%+5.55% 59.84B
Weighted average by Cap. +1.24%+3.91%-1.27%+7.23%

Financials

2026 *2027 *
Net sales 19.21B 16.86B 15.7B 14.44B 27.07B 1,836B 27.54B 186B 72.91B 910B 72.13B 70.57B 3,145B 19.72B 17.31B 16.12B 14.83B 27.79B 1,884B 28.27B 191B 74.85B 934B 74.05B 72.45B 3,229B
Net income 1.12B 987M 919M 845M 1.58B 107B 1.61B 10.9B 4.27B 53.28B 4.22B 4.13B 184B 1.45B 1.27B 1.18B 1.09B 2.04B 138B 2.08B 14.05B 5.5B 68.66B 5.44B 5.32B 237B
Net Debt 16.19B 14.21B 13.23B 12.17B 22.82B 1,547B 23.21B 157B 61.45B 767B 60.79B 59.48B 2,651B 13.82B 12.13B 11.29B 10.39B 19.47B 1,320B 19.8B 134B 52.43B 655B 51.87B 50.75B 2,262B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
-
Date Price Change
29/07/26 147.50 +1.07%
28/07/26 €145.94 +4.33%
27/07/26 €139.88 +1.82%
24/07/26 €137.38 +2.13%
23/07/26 €134.52 +0.30%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
166.34USD
Average target price
180.25USD
Spread / Average Target
+8.36%

Quarterly revenue - Rate of surprise